Clinical Trial Update: Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial of Interleukin-7 in patients with metastatic melanoma or renal cell carcinoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Renal Cell Carcinoma

Drugs mentioned

• Interleukin-7 (interleukin-7)

Snippet

Sponsor: Cytheris SA | Conditions: Kidney Cancer, Melanoma (Skin) | Phase 1 | Status: TERMINATED